Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 74 entries
Sorted by: Best Match Show Resources per page
Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes.

Iranian Red Crescent medical journal

Fathi M, Nikzamir AR, Esteghamati A, Nakhjavani M, Yekaninejad MS.
PMID: 25834741
Iran Red Crescent Med J. 2015 Feb 21;17(2):e19469. doi: 10.5812/ircmj.19469. eCollection 2015 Feb.

BACKGROUND: Angiotensin-converting enzyme (ACE) insertion/deletion (I/D) and vascular endothelial growth factor (VEGF) polymorphisms have been shown to associate with diabetic nephropathy (DN).OBJECTIVES: We examined the hypothesis that ACE-D and VEGF-G alleles act synergistically in association with DN, in patients...

Cite
Fathi M, Nikzamir AR, Esteghamati A, et al. Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes. Iran Red Crescent Med J. 2015;17(2):e19469doi: 10.5812/ircmj.19469.
Fathi, M., Nikzamir, A. R., Esteghamati, A., Nakhjavani, M., & Yekaninejad, M. S. (2015). Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes. Iranian Red Crescent medical journal, 17(2), e19469. https://doi.org/10.5812/ircmj.19469
Fathi, Mohammad, et al. "Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes." Iranian Red Crescent medical journal vol. 17,2 (2015): e19469. doi: https://doi.org/10.5812/ircmj.19469
Fathi M, Nikzamir AR, Esteghamati A, Nakhjavani M, Yekaninejad MS. Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes. Iran Red Crescent Med J. 2015 Feb 21;17(2):e19469. doi: 10.5812/ircmj.19469. eCollection 2015 Feb. PMID: 25834741; PMCID: PMC4376980.
Copy Download .nbib Format: NLM
Multifocal kaposiform hemangioendothelioma of soft tissue with bilateral pulmonary involvement in an adolescent.

Korean journal of pediatrics

Azma R, Alavi S, Khoddami M, Arzanian MT, Nourmohammad A, Esteghamati S.
PMID: 25550706
Korean J Pediatr. 2014 Nov;57(11):500-4. doi: 10.3345/kjp.2014.57.11.500. Epub 2014 Nov 30.

Kaposiform hemangioendothelioma (KHE) is a rare, locally aggressive vascular tumor of intermediate malignancy with resemblance to Kaposi sarcoma. It occurs predominantly in pediatric age groups as a cutaneous lesion with focal infiltration into the adjacent soft tissue and bone....

Cite
Azma R, Alavi S, Khoddami M, et al. Multifocal kaposiform hemangioendothelioma of soft tissue with bilateral pulmonary involvement in an adolescent. Korean J Pediatr. 2014;57(11):500-4doi: 10.3345/kjp.2014.57.11.500.
Azma, R., Alavi, S., Khoddami, M., Arzanian, M. T., Nourmohammad, A., & Esteghamati, S. (2014). Multifocal kaposiform hemangioendothelioma of soft tissue with bilateral pulmonary involvement in an adolescent. Korean journal of pediatrics, 57(11), 500-4. https://doi.org/10.3345/kjp.2014.57.11.500
Azma, Roxana, et al. "Multifocal kaposiform hemangioendothelioma of soft tissue with bilateral pulmonary involvement in an adolescent." Korean journal of pediatrics vol. 57,11 (2014): 500-4. doi: https://doi.org/10.3345/kjp.2014.57.11.500
Azma R, Alavi S, Khoddami M, Arzanian MT, Nourmohammad A, Esteghamati S. Multifocal kaposiform hemangioendothelioma of soft tissue with bilateral pulmonary involvement in an adolescent. Korean J Pediatr. 2014 Nov;57(11):500-4. doi: 10.3345/kjp.2014.57.11.500. Epub 2014 Nov 30. PMID: 25550706; PMCID: PMC4279012.
Copy Download .nbib Format: NLM
Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population.

Diabetology & metabolic syndrome

Esteghamati A, Zandieh A, Khalilzadeh O, Meysamie A, Ashraf H.
PMID: 20529329
Diabetol Metab Syndr. 2010 Jun 08;2:36. doi: 10.1186/1758-5996-2-36.

BACKGROUND: Metabolic syndrome (MetS) encompasses a cluster of coronary heart disease and diabetes mellitus risk factors. In this study, we aimed to elucidate the factors underlying the clustering of MetS components in diabetic and non-diabetic individuals.METHODS: Factor analysis was...

Cite
Esteghamati A, Zandieh A, Khalilzadeh O, et al. Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population. Diabetol Metab Syndr. 2010;2:36doi: 10.1186/1758-5996-2-36.
Esteghamati, A., Zandieh, A., Khalilzadeh, O., Meysamie, A., & Ashraf, H. (2010). Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population. Diabetology & metabolic syndrome, 236. https://doi.org/10.1186/1758-5996-2-36
Esteghamati, Alireza, et al. "Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population." Diabetology & metabolic syndrome vol. 2 (2010): 36. doi: https://doi.org/10.1186/1758-5996-2-36
Esteghamati A, Zandieh A, Khalilzadeh O, Meysamie A, Ashraf H. Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population. Diabetol Metab Syndr. 2010 Jun 08;2:36. doi: 10.1186/1758-5996-2-36. PMID: 20529329; PMCID: PMC2897775.
Copy Download .nbib Format: NLM
Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007).

Nutrition & metabolism

Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, Haghazali M, Asgari F.
PMID: 20374655
Nutr Metab (Lond). 2010 Apr 07;7:26. doi: 10.1186/1743-7075-7-26.

AIM: We have recently determined the optimal cut-off of the homeostatic model assessment of insulin resistance for the diagnosis of insulin resistance (IR) and metabolic syndrome (MetS) in non-diabetic residents of Tehran, the capital of Iran. The aim of...

Cite
Esteghamati A, Ashraf H, Khalilzadeh O, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond). 2010;7:26doi: 10.1186/1743-7075-7-26.
Esteghamati, A., Ashraf, H., Khalilzadeh, O., Zandieh, A., Nakhjavani, M., Rashidi, A., Haghazali, M., & Asgari, F. (2010). Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutrition & metabolism, 726. https://doi.org/10.1186/1743-7075-7-26
Esteghamati, Alireza, et al. "Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007)." Nutrition & metabolism vol. 7 (2010): 26. doi: https://doi.org/10.1186/1743-7075-7-26
Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, Haghazali M, Asgari F. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond). 2010 Apr 07;7:26. doi: 10.1186/1743-7075-7-26. PMID: 20374655; PMCID: PMC2857836.
Copy Download .nbib Format: NLM
Temporal analysis of the incidence of meningitis in the Tehran metropolitan area, 1999-2005.

Population health metrics

Mosavi-Jarrahi A, Esteghamati A, Asgari F, Heidarnia M, Mousavi-Jarrahi Y, Goya M.
PMID: 20030846
Popul Health Metr. 2009 Dec 23;7:19. doi: 10.1186/1478-7954-7-19.

OBJECTIVES: The aim of this study was to describe the temporal determinants of meningitis incidence in the population living in the Tehran metropolis.METHODS: All cases of meningitis reported to health districts throughout the Tehran metropolis from 1999 to 2005...

Cite
Mosavi-Jarrahi A, Esteghamati A, Asgari F, et al. Temporal analysis of the incidence of meningitis in the Tehran metropolitan area, 1999-2005. Popul Health Metr. 2009;7:19doi: 10.1186/1478-7954-7-19.
Mosavi-Jarrahi, A., Esteghamati, A., Asgari, F., Heidarnia, M., Mousavi-Jarrahi, Y., & Goya, M. (2009). Temporal analysis of the incidence of meningitis in the Tehran metropolitan area, 1999-2005. Population health metrics, 719. https://doi.org/10.1186/1478-7954-7-19
Mosavi-Jarrahi, Alireza, et al. "Temporal analysis of the incidence of meningitis in the Tehran metropolitan area, 1999-2005." Population health metrics vol. 7 (2009): 19. doi: https://doi.org/10.1186/1478-7954-7-19
Mosavi-Jarrahi A, Esteghamati A, Asgari F, Heidarnia M, Mousavi-Jarrahi Y, Goya M. Temporal analysis of the incidence of meningitis in the Tehran metropolitan area, 1999-2005. Popul Health Metr. 2009 Dec 23;7:19. doi: 10.1186/1478-7954-7-19. PMID: 20030846; PMCID: PMC2806853.
Copy Download .nbib Format: NLM
Association of depression and anxiety with diabetes mellitus type 2 concerning some sociological factors.

Iranian Red Crescent medical journal

Palizgir M, Bakhtiari M, Esteghamati A.
PMID: 24578829
Iran Red Crescent Med J. 2013 Aug;15(8):644-8. doi: 10.5812/ircmj.12107. Epub 2013 Aug 05.

BACKGROUND: Diabetes is a metabolic disorder with a high worldwide prevalence. It has been reported that diabetic patients are more prone to depression and anxiety.OBJECTIVES: This study aimed to evaluate the prevalence of depression and anxiety among diabetic patients...

Cite
Palizgir M, Bakhtiari M, Esteghamati A. Association of depression and anxiety with diabetes mellitus type 2 concerning some sociological factors. Iran Red Crescent Med J. 2013;15(8):644-8doi: 10.5812/ircmj.12107.
Palizgir, M., Bakhtiari, M., & Esteghamati, A. (2013). Association of depression and anxiety with diabetes mellitus type 2 concerning some sociological factors. Iranian Red Crescent medical journal, 15(8), 644-8. https://doi.org/10.5812/ircmj.12107
Palizgir, Maryam, et al. "Association of depression and anxiety with diabetes mellitus type 2 concerning some sociological factors." Iranian Red Crescent medical journal vol. 15,8 (2013): 644-8. doi: https://doi.org/10.5812/ircmj.12107
Palizgir M, Bakhtiari M, Esteghamati A. Association of depression and anxiety with diabetes mellitus type 2 concerning some sociological factors. Iran Red Crescent Med J. 2013 Aug;15(8):644-8. doi: 10.5812/ircmj.12107. Epub 2013 Aug 05. PMID: 24578829; PMCID: PMC3918186.
Copy Download .nbib Format: NLM
Comparing the Predictive Ability of Prognostic Models in Ischemic Stroke; Derivation, Validation, and Discrimination Beyond the ROC Curve.

Frontiers in neurology

Esteghamati A, Hafezi-Nejad N, Sheikhbahaei S, Heidari B, Zandieh A, Eslami V.
PMID: 24478755
Front Neurol. 2014 Jan 27;5:9. doi: 10.3389/fneur.2014.00009. eCollection 2014.

No abstract available.

Cite
Esteghamati A, Hafezi-Nejad N, Sheikhbahaei S, et al. Comparing the Predictive Ability of Prognostic Models in Ischemic Stroke; Derivation, Validation, and Discrimination Beyond the ROC Curve. Front Neurol. 2014;5:9doi: 10.3389/fneur.2014.00009.
Esteghamati, A., Hafezi-Nejad, N., Sheikhbahaei, S., Heidari, B., Zandieh, A., & Eslami, V. (2014). Comparing the Predictive Ability of Prognostic Models in Ischemic Stroke; Derivation, Validation, and Discrimination Beyond the ROC Curve. Frontiers in neurology, 59. https://doi.org/10.3389/fneur.2014.00009
Esteghamati, Alireza, et al. "Comparing the Predictive Ability of Prognostic Models in Ischemic Stroke; Derivation, Validation, and Discrimination Beyond the ROC Curve." Frontiers in neurology vol. 5 (2014): 9. doi: https://doi.org/10.3389/fneur.2014.00009
Esteghamati A, Hafezi-Nejad N, Sheikhbahaei S, Heidari B, Zandieh A, Eslami V. Comparing the Predictive Ability of Prognostic Models in Ischemic Stroke; Derivation, Validation, and Discrimination Beyond the ROC Curve. Front Neurol. 2014 Jan 27;5:9. doi: 10.3389/fneur.2014.00009. eCollection 2014. PMID: 24478755; PMCID: PMC3902471.
Copy Download .nbib Format: NLM
The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus.

Journal of diabetes and metabolic disorders

Farshchi A, Esteghamati A, Sari AA, Kebriaeezadeh A, Abdollahi M, Dorkoosh FA, Khamseh ME, Aghili R, Keshtkar A, Ebadi M.
PMID: 24593991
J Diabetes Metab Disord. 2014 Mar 04;13(1):42. doi: 10.1186/2251-6581-13-42.

BACKGROUND: To evaluate the cost of diabetes related micro- and macrovascular complications in Iranian people with type 2 diabetes mellitus.METHODS: In routine clinical practice, people with type 2 diabetes mellitus were assessed for 10 years at a diabetes care...

Cite
Farshchi A, Esteghamati A, Sari AA, et al. The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus. J Diabetes Metab Disord. 2014;13(1):42doi: 10.1186/2251-6581-13-42.
Farshchi, A., Esteghamati, A., Sari, A. A., Kebriaeezadeh, A., Abdollahi, M., Dorkoosh, F. A., Khamseh, M. E., Aghili, R., Keshtkar, A., & Ebadi, M. (2014). The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus. Journal of diabetes and metabolic disorders, 13(1), 42. https://doi.org/10.1186/2251-6581-13-42
Farshchi, Amir, et al. "The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus." Journal of diabetes and metabolic disorders vol. 13,1 (2014): 42. doi: https://doi.org/10.1186/2251-6581-13-42
Farshchi A, Esteghamati A, Sari AA, Kebriaeezadeh A, Abdollahi M, Dorkoosh FA, Khamseh ME, Aghili R, Keshtkar A, Ebadi M. The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus. J Diabetes Metab Disord. 2014 Mar 04;13(1):42. doi: 10.1186/2251-6581-13-42. PMID: 24593991; PMCID: PMC3975900.
Copy Download .nbib Format: NLM
Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review.

International journal of endocrinology and metabolism

Rabizadeh S, Nakhjavani M, Esteghamati A.
PMID: 31372172
Int J Endocrinol Metab. 2019 Apr 22;17(2):e84353. doi: 10.5812/ijem.84353. eCollection 2019 Apr.

CONTEXT: Most recently developed anti-hyperglycemic drugs have offered cardiovascular and renal benefits. In this narrative review, we discuss the cardiovascular and renal benefits of novel antidiabetic drugs, sodium glucose cotransporter type 2 (SGLT2) inhibitors, in type 2 diabetes.EVIDENCE ACQUISITION:...

Cite
Rabizadeh S, Nakhjavani M, Esteghamati A. Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review. Int J Endocrinol Metab. 2019;17(2):e84353doi: 10.5812/ijem.84353.
Rabizadeh, S., Nakhjavani, M., & Esteghamati, A. (2019). Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review. International journal of endocrinology and metabolism, 17(2), e84353. https://doi.org/10.5812/ijem.84353
Rabizadeh, Soghra, et al. "Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review." International journal of endocrinology and metabolism vol. 17,2 (2019): e84353. doi: https://doi.org/10.5812/ijem.84353
Rabizadeh S, Nakhjavani M, Esteghamati A. Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review. Int J Endocrinol Metab. 2019 Apr 22;17(2):e84353. doi: 10.5812/ijem.84353. eCollection 2019 Apr. PMID: 31372172; PMCID: PMC6628616.
Copy Download .nbib Format: NLM
Clear cell sarcoma of the kidney misdiagnosed as mesoblastic nephroma: a case report and review of the literature.

Ecancermedicalscience

Alavi S, Khoddami M, Yazdi MK, Dehghanian P, Esteghamati S.
PMID: 23634181
Ecancermedicalscience. 2013 Apr 24;7:311. doi: 10.3332/ecancer.2013.311. Print 2013.

Clear cell sarcoma of the kidney (CCSK) is a rare renal neoplasm of paediatrics, making up about 3% of all renal tumours in paediatrics, with a high tendency for developing bone metastasis. A seven year-old boy was referred to...

Cite
Alavi S, Khoddami M, Yazdi MK, et al. Clear cell sarcoma of the kidney misdiagnosed as mesoblastic nephroma: a case report and review of the literature. Ecancermedicalscience. 2013;7:311doi: 10.3332/ecancer.2013.311.
Alavi, S., Khoddami, M., Yazdi, M. K., Dehghanian, P., & Esteghamati, S. (2013). Clear cell sarcoma of the kidney misdiagnosed as mesoblastic nephroma: a case report and review of the literature. Ecancermedicalscience, 7311. https://doi.org/10.3332/ecancer.2013.311
Alavi, Samin, et al. "Clear cell sarcoma of the kidney misdiagnosed as mesoblastic nephroma: a case report and review of the literature." Ecancermedicalscience vol. 7 (2013): 311. doi: https://doi.org/10.3332/ecancer.2013.311
Alavi S, Khoddami M, Yazdi MK, Dehghanian P, Esteghamati S. Clear cell sarcoma of the kidney misdiagnosed as mesoblastic nephroma: a case report and review of the literature. Ecancermedicalscience. 2013 Apr 24;7:311. doi: 10.3332/ecancer.2013.311. Print 2013. PMID: 23634181; PMCID: PMC3634723.
Copy Download .nbib Format: NLM
Comparing serum concentration of spexin among patients with metabolic syndrome, healthy overweight/obese, and normal-weight individuals.

Medical journal of the Islamic Republic of Iran

Bitarafan V, Esteghamati A, Azam K, Yosaee S, Djafarian K.
PMID: 31696087
Med J Islam Repub Iran. 2019 Sep 06;33:93. doi: 10.34171/mjiri.33.93. eCollection 2019.

No abstract available.

Cite
Bitarafan V, Esteghamati A, Azam K, et al. Comparing serum concentration of spexin among patients with metabolic syndrome, healthy overweight/obese, and normal-weight individuals. Med J Islam Repub Iran. 2019;33:93doi: 10.34171/mjiri.33.93.
Bitarafan, V., Esteghamati, A., Azam, K., Yosaee, S., & Djafarian, K. (2019). Comparing serum concentration of spexin among patients with metabolic syndrome, healthy overweight/obese, and normal-weight individuals. Medical journal of the Islamic Republic of Iran, 3393. https://doi.org/10.34171/mjiri.33.93
Bitarafan, Vida, et al. "Comparing serum concentration of spexin among patients with metabolic syndrome, healthy overweight/obese, and normal-weight individuals." Medical journal of the Islamic Republic of Iran vol. 33 (2019): 93. doi: https://doi.org/10.34171/mjiri.33.93
Bitarafan V, Esteghamati A, Azam K, Yosaee S, Djafarian K. Comparing serum concentration of spexin among patients with metabolic syndrome, healthy overweight/obese, and normal-weight individuals. Med J Islam Repub Iran. 2019 Sep 06;33:93. doi: 10.34171/mjiri.33.93. eCollection 2019. PMID: 31696087; PMCID: PMC6825375.
Copy Download .nbib Format: NLM
Improvement in Redox Homeostasis after Cytoreductive Surgery in Colorectal Adenocarcinoma.

Oxidative medicine and cellular longevity

Salehi SS, Mirmiranpour H, Rabizadeh S, Esteghamati A, Tomasello G, Alibakhshi A, Najafi N, Rajab A, Nakhjavani M.
PMID: 34381561
Oxid Med Cell Longev. 2021 Jul 31;2021:8864905. doi: 10.1155/2021/8864905. eCollection 2021.

Colorectal cancer (CRC) as one the most common cancer type is associated with oxidative stress. Surgery is the only curative modality for early-stage CRC. The aim of this study was to evaluate the oxidative damage biomarkers as well as...

Cite
Salehi SS, Mirmiranpour H, Rabizadeh S, et al. Improvement in Redox Homeostasis after Cytoreductive Surgery in Colorectal Adenocarcinoma. Oxid Med Cell Longev. 2021;2021:8864905doi: 10.1155/2021/8864905.
Salehi, S. S., Mirmiranpour, H., Rabizadeh, S., Esteghamati, A., Tomasello, G., Alibakhshi, A., Najafi, N., Rajab, A., & Nakhjavani, M. (2021). Improvement in Redox Homeostasis after Cytoreductive Surgery in Colorectal Adenocarcinoma. Oxidative medicine and cellular longevity, 20218864905. https://doi.org/10.1155/2021/8864905
Salehi, Salome Sadat, et al. "Improvement in Redox Homeostasis after Cytoreductive Surgery in Colorectal Adenocarcinoma." Oxidative medicine and cellular longevity vol. 2021 (2021): 8864905. doi: https://doi.org/10.1155/2021/8864905
Salehi SS, Mirmiranpour H, Rabizadeh S, Esteghamati A, Tomasello G, Alibakhshi A, Najafi N, Rajab A, Nakhjavani M. Improvement in Redox Homeostasis after Cytoreductive Surgery in Colorectal Adenocarcinoma. Oxid Med Cell Longev. 2021 Jul 31;2021:8864905. doi: 10.1155/2021/8864905. eCollection 2021. PMID: 34381561; PMCID: PMC8352694.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 74 entries